Filippo Crea
doi : 10.1093/eurheartj/ehac785
European Heart Journal, Volume 44, Issue 2, 7 January 2023, Pages 73–76
Ilaria Capua, Eligio Piccolo Ilaria Capua, Eligio Piccolo
doi : 10.1093/eurheartj/ehac593
European Heart Journal, Volume 44, Issue 2, 7 January 2023, Pages 77–79
Judith Ozkan
doi : 10.1093/eurheartj/ehac610
European Heart Journal, Volume 44, Issue 2, 7 January 2023, Pages 80–81
Judith Ozkan
doi : 10.1093/eurheartj/ehac623
European Heart Journal, Volume 44, Issue 2, 7 January 2023, Pages 82–86
Daniela Pedicino, Giovanna Liuzzo
doi : 10.1093/eurheartj/ehac636
European Heart Journal, Volume 44, Issue 2, 7 January 2023, Pages 87–88
Jack W O’Sullivan, Euan A Ashley, Perry M Elliott
doi : 10.1093/eurheartj/ehac648
European Heart Journal, Volume 44, Issue 2, 7 January 2023, Pages 89–99
Cardiometabolic diseases contribute more to global morbidity and mortality than any other group of disorders. Polygenic risk scores (PRSs), the weighted summation of individually small-effect genetic variants, represent an advance in our ability to predict the development and complications of cardiometabolic diseases.
Samuel Heuts, Can Gollmann-Tepeköylü, Ellen J S Denessen, Jules R Olsthoorn, Jamie L R Romeo, Jos G Maessen, Arnoud W J van ‘t Hof, Otto Bekers, Ola Hammarsten, Leo Pölzl, Johannes Holfeld, Nikolaos Bonaros, Iwan C C van der Horst, Sean M Davidson, Matthias Thielmann, Alma M A Mingels
doi : 10.1093/eurheartj/ehac604
European Heart Journal, Volume 44, Issue 2, 7 January 2023, Pages 100–112
The use of biomarkers is undisputed in the diagnosis of primary myocardial infarction (MI), but their value for identifying MI is less well studied in the postoperative phase following coronary artery bypass grafting (CABG).
Hernan Mejia-Renteria, Alejandro Travieso, Jordi A MatÃas-Guiu, Miguel Yus, Carolina Espejo-Paeres, Francesca Finocchiaro, Sara Fernández, Carlos Ignacio Gomez-Escalonilla, Blanca Reneses-Prieto, Maria Dulcenombre Gómez-Garré, Alfonso Delgado-Alvarez, Ana Bustos, Leopoldo Perez de Isla, Jose Juan Gomez de Diego, Javier Modrego-Martin, Adriana Ortega-Hernandez, Petros Papadopoulos, Juan Arrazola-GarcÃa, Jorge MatÃas-Guiu, Javier Escaned
doi : 10.1093/eurheartj/ehac521
European Heart Journal, Volume 44, Issue 2, 7 January 2023, Pages 113–125
It remains unknown whether the presence of coronary microcirculatory dysfunction (CMD) correlates with its equivalent condition in the brain, cerebral small vessel disease (CSVD). The cerebral-coronary connection (C3), a prospective blinded study, investigated the prevalence of CMD in patients with coronary artery disease (CAD) and its association with CSVD and cognitive function.
Carl J Pepine, C Noel Bairey Merz
doi : 10.1093/eurheartj/ehac570
European Heart Journal, Volume 44, Issue 2, 7 January 2023, Pages 126–128
Kausik K Ray, Frederick J Raal, David G Kallend, Mark J Jaros, Wolfgang Koenig, Lawrence A Leiter, Ulf Landmesser, Gregory G Schwartz, David Lawrence, Andrew Friedman, Lorena Garcia Conde, R Scott Wright, ORION Phase III investigators
doi : 10.1093/eurheartj/ehac594
European Heart Journal, Volume 44, Issue 2, 7 January 2023, Pages 129–138
Inclisiran, an siRNA administered twice-yearly, significantly reduced LDL cholesterol (LDL-C) in Phase III trials. Whether lowering LDL-C with inclisiran translates into a lower risk of cardiovascular (CV) events is not yet established.
Raul D Santos, Viviane Z Rocha
doi : 10.1093/eurheartj/ehac656
European Heart Journal, Volume 44, Issue 2, 7 January 2023, Pages 139–141
Danilo Neglia, Riccardo Liga, Alessia Gimelli, Tomaž Podlesnikar, Marta Cvijić, Gianluca Pontone, Marcelo Haertel Miglioranza, Andrea Igoren Guaricci, Sara Seitun, Alberto Clemente, Alexey Sumin, João Vitola, Antti Saraste, Christian Paunonen, Ching-Hui Sia, Filipp Paleev, Leyla Elif Sade, Jose Luis Zamorano, Natallia Maroz-Vadalazhskaya, Constantinos Anagnostopoulos, Filipe Macedo, Juhani Knuuti, Thor Edvardsen, Bernard Cosyns, Steffen E Petersen, Julien Magne, Cecile Laroche, Clara Berlè, Bogdan A Popescu, Victoria Delgado, EURECA Investigators
doi : 10.1093/eurheartj/ehac640
European Heart Journal, Volume 44, Issue 2, 7 January 2023, Pages 142–158
The prospective, multicentre EURECA registry assessed the use of imaging and adoption of the European Society of Cardiology (ESC) Guidelines (GL) in patients with chronic coronary syndromes (CCS).
Pieter van der Bijl, Jan Stassen, Jeroen J Bax
doi : 10.1093/eurheartj/ehac630
European Heart Journal, Volume 44, Issue 2, 7 January 2023, Pages 159–161
Matteo Armillotta, Alberto Foà , Carmine Pizzi
doi : 10.1093/eurheartj/ehac537
European Heart Journal, Volume 44, Issue 2, 7 January 2023, Page 162
Hazem Omran
doi : 10.1093/eurheartj/ehac539
European Heart Journal, Volume 44, Issue 2, 7 January 2023, Pages 163–164
Sylvain Ploux, Marc Strik, Hubert Cochet, Pierre Bordachar
doi : 10.1093/eurheartj/ehac675
European Heart Journal, Volume 44, Issue 2, 7 January 2023, Page 165
Tao Chen, Hang Zhou, Jun Guo, Yundai Chen
doi : 10.1093/eurheartj/ehac478
European Heart Journal, Volume 44, Issue 2, 7 January 2023, Page 166
doi : 10.1093/eurheartj/ehac728
European Heart Journal, Volume 44, Issue 2, 7 January 2023, Page 138
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟